What is the treatment for anaplasmosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Anaplasmosis

Doxycycline is the treatment of choice for all patients with suspected or confirmed anaplasmosis, regardless of age or pregnancy status, and should be initiated promptly without waiting for laboratory confirmation. 1

First-Line Treatment

  • Adults: Doxycycline 100 mg orally (or intravenously if unable to take oral medication) twice daily for 10 days 1
  • Children: Doxycycline 4 mg/kg per day in 2 divided doses (maximum 100 mg per dose) orally or intravenously for 10 days 1

Clinical Response Expectations

  • Patients typically show clinical improvement within 24-48 hours after starting doxycycline 1
  • Failure to respond within 48 hours should prompt reevaluation for:
    • Alternative diagnoses
    • Coinfection (particularly with Babesia microti or Borrelia burgdorferi in endemic areas)
    • Complications of anaplasmosis 1

Alternative Treatment Options

For patients with severe doxycycline allergy or pregnancy:

  • Rifampin 300 mg orally twice daily for adults or 10 mg/kg twice daily for children (maximum 300 mg per dose) for 7-10 days 1
  • Important caution: Rifampin should only be used when anaplasmosis is strongly suspected and Rocky Mountain Spotted Fever (RMSF) has been ruled out, as rifampin is not effective against RMSF 1

Contraindicated Treatments

The following antibiotics are ineffective or potentially harmful for anaplasmosis:

  • Chloramphenicol (ineffective against anaplasmosis) 1
  • Fluoroquinolones (may lead to relapse despite initial improvement) 1, 2
  • Beta-lactams, macrolides, aminoglycosides, and sulfonamides 1
  • Sulfonamides (may worsen disease severity) 1

Monitoring and Follow-up

  • Close observation of clinical response is essential, particularly for patients treated with rifampin 1
  • Monitor for resolution of:
    • Fever
    • Headache
    • Myalgia
    • Laboratory abnormalities (thrombocytopenia, leukopenia, elevated liver enzymes) 1

Special Considerations

Severe Disease

  • Hospitalization may be required for severe cases
  • Approximately 7% of hospitalized patients require intensive care 1
  • Complications can include ARDS, peripheral neuropathies, coagulopathies, rhabdomyolysis, and opportunistic infections 1, 3
  • In cases of anaplasmosis-induced hemophagocytic lymphohistiocytosis (HLH), combination of doxycycline with immunosuppressive therapy may be beneficial 3

Coinfections

  • The tick vector (Ixodes scapularis/pacificus) can transmit multiple pathogens
  • Consider coinfection with Borrelia burgdorferi or Babesia microti if response to treatment is delayed 1
  • Doxycycline will treat both anaplasmosis and Lyme disease, but will not treat babesiosis 1

Prevention

  • Prophylactic antibiotics after tick bites are not recommended for prevention of anaplasmosis 1
  • Treatment of asymptomatic seropositive individuals is not recommended 1

Remember that early treatment is crucial to prevent complications and reduce mortality, which is less than 1% with appropriate treatment 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis.

Vector borne and zoonotic diseases (Larchmont, N.Y.), 2006

Research

Human Granulocytic Anaplasmosis.

Infectious disease clinics of North America, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.